Novartis set to launch new Zolgensma trial to expand use
August 3, 2021Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
Cannabis-based oral spray could kill brain tumours, study to launch next year
August 3, 2021Manufacturing and Production, Medical Communications, Research and Development
The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
Sanofi to buy Translate Bio for $3.2 billion
August 3, 2021Manufacturing and Production
Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal.This is part of Sanofi’s goal …
NICE approves UCB’s bimekizumab through expedited review process
August 3, 2021Manufacturing and Production
NICE has published draft guidance on the first treatment to use its new review process, recommending UCB’s bimekizumab for treating …
FDA approves AstraZeneca’s anifrolumab for treating lupus
August 3, 2021Manufacturing and Production
The FDA has approved Saphnelo (anifrolumab) for the treatment of moderate-to-severe systemic lupus erythematosus (SLE), the most common form of …
Pulse oxygen monitors less effective on darker skin, MHRA warns
August 2, 2021Sales and Marketing
The MHRA has warned that pulse oxygen monitors, devices designed to spot early signs of dangerous falls in oxygen levels …
BioMed X to research autoimmune diseases and drug delivery with Janssen
August 2, 2021Sales and Marketing
BioMed X Institute is to start two new research programs in the field of autoimmune diseases and drug delivery in …
Republican report says COVID-19 leaked from Chinese lab
August 2, 2021Sales and Marketing
A report released by the US Republican party on Monday has concluded that the virus that caused the COVID-19 pandemic …
Double jabbed from EU and US no longer need to quarantine in UK
August 2, 2021Sales and Marketing
Arrivals to the UK from the EU and US no longer have to quarantine if they have been double jabbed …
Pfizer and Moderna hike vaccine prices in EU
August 2, 2021Sales and Marketing
Pfizer and Moderna have raised the prices of their COVID-19 vaccines in the EU, as reported in the Financial Times.Pfizer-BioNTech …
CMA fines Advanz over £100 million over pricing of crucial thyroid drug
July 30, 2021Medical Communications
The CMA has fined the pharmaceutical company Advanz over £100 million after it charged excessive and unfair prices for supplying …
FDA: Viatris’ insulin deemed ‘interchangeable’ biosimilar
July 30, 2021Medical Communications
Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …
COVID travel update: Double jabbed from US and EU could avoid UK quarantine
July 30, 2021Medical Communications
UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …
Positive data reported on Alnylam’s investigational RNAi therapeutic for ultra-rare disease
July 30, 2021Medical Communications
Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …
FDA grants Huntingdon disease treatment orphan-drug designation
July 30, 2021Medical Communications
The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …
Urine test developed that can detect brain tumours for first time
July 29, 2021Scientists from Cancer Research UK have developed a simple urine test that can detect a common type of brain tumours …
Study shows significant improvement of survival in infants with SMA
July 29, 2021sma
Results from the Evrysdi part 2 global FIREFISH study show significant improvement in survival and motor milestones in babies with …
$500,000 grant awarded to NRG Therapeutics for Parkinson’s research
July 29, 2021The Michael J Fox Foundation for Parkinson’s Research (MJFF) has awarded a $500,000 grant to NRG Therapeutics to support its …
Dupilumab meets primary endpoint in skin disease Phase III trial
July 29, 2021Dupilumab has met its primary endpoint in a Phase III trial for patients with moderate-to-severe chronic spontaneous urticaria (CSU), an …
NHS England appoints first ever female Chief Executive
July 29, 2021NHS England has announced the appointment of Amanda Prichard, the first woman to hold the position. She will replace Sir …
Latest content
